PortfoliosLab logo

Artelo Biosciences, Inc. (ARTL)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINUS04301G2012
CUSIP04301G201
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.38
Year Range$0.30 - $1.17
EMA (50)$0.35
EMA (200)$0.51
Average Volume$303.20K
Market Capitalization$16.19M

ARTLShare Price Chart


Chart placeholderClick Calculate to get results

ARTLPerformance

The chart shows the growth of $10,000 invested in Artelo Biosciences, Inc. in Nov 2017 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $943 for a total return of roughly -90.57%. All prices are adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%MarchAprilMayJuneJulyAugust
-11.29%
-9.64%
ARTL (Artelo Biosciences, Inc.)
Benchmark (^GSPC)

ARTLReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M24.83%8.19%
6M-7.14%-7.42%
YTD-27.36%-13.03%
1Y-60.73%-5.85%
5Y-48.23%11.70%
10Y-48.23%11.70%

ARTLMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-19.08%-5.48%13.35%-15.11%-13.35%-4.23%7.26%10.88%
202131.23%92.07%-11.41%-19.02%-6.06%-4.03%-15.97%-8.90%-13.17%-9.48%-12.01%-17.62%
2020-24.81%-47.29%-10.28%22.92%8.47%-5.47%-4.96%-16.52%3.44%-53.88%34.06%18.89%
2019-13.04%20.00%0.00%-8.33%0.00%-47.73%-28.48%-40.73%10.84%-7.93%22.50%10.76%
201835.00%2.22%-27.54%5.00%19.05%1.60%2.36%0.00%14.62%-16.78%-12.90%6.48%
2017100.00%0.00%

ARTLSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Artelo Biosciences, Inc. Sharpe ratio is -0.80. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.80
-0.31
ARTL (Artelo Biosciences, Inc.)
Benchmark (^GSPC)

ARTLDividend History


Artelo Biosciences, Inc. doesn't pay dividends

ARTLDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-98.25%
-13.58%
ARTL (Artelo Biosciences, Inc.)
Benchmark (^GSPC)

ARTLWorst Drawdowns

The table below shows the maximum drawdowns of the Artelo Biosciences, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Artelo Biosciences, Inc. is 98.60%, recorded on Jul 5, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.6%Jan 19, 2018871Jul 5, 2022
-20%Dec 11, 20172Dec 21, 20171Jan 2, 20183

ARTLVolatility Chart

Current Artelo Biosciences, Inc. volatility is 51.33%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%MarchAprilMayJuneJulyAugust
51.33%
19.67%
ARTL (Artelo Biosciences, Inc.)
Benchmark (^GSPC)